Read Time:39 Second
The Food and Drug Administration on Monday authorized a test developed by Laboratory Corporation of America Holdings that allows people in the U.S. to self-test for respiratory syncytial virus (RSV), a type of common cold, as well as the flu and COVID-19. The test does not require a prescription. People swab at home and send the test by mail to a Labcorp lab. Results are then made available in an online portal. Teens and children are also authorized to test with the support of adults. Labcorp’s stock has tumbled 22.5% this year, while the broader S&P 500 is down 15.5%.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
0
0